HomeNewsAnimal healthcare

Animal Healthcare

Jump to

Ideas For Profit | Cadila: COVID opportunity, complex pharma pipeline offer strong risk reward

Cadila’s stock was primed by a series of potential roll outs to meet the COVID-19 challenge. Beyond COVID, the company is steadily building up its injectable and biosimilars portfolio - the areas to look at for the longer term.
Cadila: All in for COVID while keeping a tab on complex pharma

Cadila's stock has been primed by a series of potential rollouts to meet the COVID challenge
Hester Biosciences Q1 net profit rises to Rs 4.66 cr

The company's net sales increased 5 percent at Rs 24.53 crore in the June quarter as against Rs 23.30 crore in the same quarter last year, a company statement said here

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Animal Healthcare

Ideas For Profit | Cadila: COVID opportunity, complex pharma pipeline offer strong risk reward

Cadila: All in for COVID while keeping a tab on complex pharma

Hester Biosciences Q1 net profit rises to Rs 4.66 cr